Compare $VTGN vs $XCUR | Chartloom

Compare

$VTGN vs $XCUR

Vistagen Therapeutics Inc · Exicure Inc

VTGN

Vistagen Therapeutics Inc

XCUR

Exicure Inc

Compare $VTGN vs $XCUR

Comparing Vistagen Therapeutics Inc and Exicure Inc

VTGNVistagen Therapeutics Inc

XCURExicure Inc

VTGNVistagen Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

278.5%

YTD performance

-65.2%

52W performance

-94.1%

FCF yield

-644.0%

XCURExicure Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-80.3%

FCF yield

-105.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

VTGN

XCUR

Detailed metrics comparison

VTGN

Vistagen Therapeutics Inc

XCUR

Exicure Inc

Market Cap

VTGN$10M

XCUR$7M

Enterprise Value

VTGN$-7M

XCUR$5M

Price

VTGN$0.24

XCUR$1.05

P/E Ratio

VTGNN/A

XCURN/A

P/S Ratio

VTGN3.87x

XCUR14.24x

EV/Sales

VTGN-2.92x

XCUR10.81x

EV/EBITDA

VTGN0.00x

XCUR0.90x

P/B Ratio

VTGN0.56x

XCUR7.29x

P/FCF Ratio

VTGNN/A

XCURN/A

EV/FCF

VTGN0.12x

XCUR-0.71x

PEG Ratio

VTGNN/A

XCURN/A

Forward P/E (NTM)

VTGNN/A

XCURN/A

Forward P/S (NTM)

VTGNN/A

XCURN/A

Revenue (TTM)

VTGN$3M

XCUR$0

Revenue Growth (YoY)

VTGN278.5%

XCURN/A

Forward Rev Growth

VTGN4633.2%

XCUR0.0%

Gross Margin (TTM)

VTGN0.0%

XCUR0.0%

Operating Margin (TTM)

VTGN0.0%

XCUR0.0%

EBITDA Margin (TTM)

VTGN-2775.9%

XCUR0.0%

Net Margin (TTM)

VTGN-2702.6%

XCUR0.0%

FCF Margin (TTM)

VTGN-2493.3%

XCURN/A

Net Income (TTM)

VTGN$-68M

XCUR$-8M

FCF (TTM)

VTGN$-62M

XCUR$-7M

EPS (TTM)

VTGN-$1.57

XCUR-$1.30

ROE (TTM)

VTGN-15259.0%

XCUR-23791.0%

ROA (TTM)

VTGN-11745.0%

XCUR-6198.0%

ROIC (TTM)

VTGN-15162.0%

XCUR-23791.0%

Cash

VTGN$17M

XCUR$2M

Debt

VTGN$0

XCUR$0

Net Cash/Debt

VTGN$17M

XCUR$2M

Current Ratio (TTM)

VTGN3.07x

XCUR0.56x

Quick Ratio (TTM)

VTGN2.84x

XCUR0.43x

Debt/Equity (TTM)

VTGN0.00x

XCUR0.00x

Debt/Assets (TTM)

VTGN0.0%

XCUR0.0%

Interest Coverage (TTM)

VTGNN/A

XCURN/A

Net Debt/EBITDA (TTM)

VTGN0.00x

XCUR0.00x

Beta

VTGN0.49

XCUR3.86

52W Performance

VTGN-94.1%

XCUR-80.3%

YTD Performance

VTGN-65.2%

XCUR-81.2%

% from 52W High

VTGN-95.4%

XCUR-88.9%

% from 52W Low

VTGN19.2%

XCUR12.2%

Asset Turnover (TTM)

VTGN0.04x

XCUR0.05x

FCF Yield (TTM)

VTGN-644.0%

XCUR-105.0%

Earnings Yield (TTM)

VTGN-698.0%

XCUR-123.9%

Dividend Yield (TTM)

VTGNN/A

XCURN/A

Rule of 40

VTGN-2,214.8

XCUR0.0

EV/GP/RG

VTGNN/A

XCURN/A

Ticker research

View VTGN research View XCUR research

Metric	VTGN Vistagen Therapeutics Inc	XCUR Exicure Inc
Market & Valuation
Market Cap	$10M	$7M
Enterprise Value	$-7M	$5M
Price	$0.24	$1.05
P/E Ratio	N/A	N/A
P/S Ratio	3.87x	14.24x
EV/Sales	-2.92x	10.81x
EV/EBITDA	0.00x	0.90x
P/B Ratio	0.56x	7.29x
P/FCF Ratio	N/A	N/A
EV/FCF	0.12x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3M	$0
Revenue Growth (YoY)	278.5%	N/A
Forward Rev Growth	4633.2%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2775.9%	0.0%
Net Margin (TTM)	-2702.6%	0.0%
FCF Margin (TTM)	-2493.3%	N/A
Net Income (TTM)	$-68M	$-8M
FCF (TTM)	$-62M	$-7M
EPS (TTM)	-$1.57	-$1.30
ROE (TTM)	-15259.0%	-23791.0%
ROA (TTM)	-11745.0%	-6198.0%
ROIC (TTM)	-15162.0%	-23791.0%
Financial Health
Cash	$17M	$2M
Debt	$0	$0
Net Cash/Debt	$17M	$2M
Current Ratio (TTM)	3.07x	0.56x
Quick Ratio (TTM)	2.84x	0.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	3.86
52W Performance	-94.1%	-80.3%
YTD Performance	-65.2%	-81.2%
% from 52W High	-95.4%	-88.9%
% from 52W Low	19.2%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.05x
FCF Yield (TTM)	-644.0%	-105.0%
Earnings Yield (TTM)	-698.0%	-123.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,214.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View VTGN research	View XCUR research

Valuation

P/S Ratio

VTGN

3.87x

XCUR

14.24x

EV/FCF

XCUR

-0.71x

VTGN

0.12x

Growth & revenue

Revenue Growth TTM

VTGN

278.5%

Forward Revenue Growth

VTGN

4633.2%

XCUR

0.0%

Profitability & performance

Gross Margin

VTGN

0.0%

XCUR

0.0%

ROE

VTGN

-15259.0%

XCUR

-23791.0%

FCF Yield %

XCUR

-105.0%

VTGN

-644.0%

52-Week Performance

XCUR

-80.3%

VTGN

-94.1%

Detailed metrics comparison

VTGN

Vistagen Therapeutics Inc

XCUR

Exicure Inc

Market Cap

VTGN$10M

XCUR$7M

Enterprise Value

VTGN$-7M

XCUR$5M

Price

VTGN$0.24

XCUR$1.05

P/E Ratio

VTGNN/A

XCURN/A

P/S Ratio

VTGN3.87x

XCUR14.24x

EV/Sales

VTGN-2.92x

XCUR10.81x

EV/EBITDA

VTGN0.00x

XCUR0.90x

P/B Ratio

VTGN0.56x

XCUR7.29x

P/FCF Ratio

VTGNN/A

XCURN/A

EV/FCF

VTGN0.12x

XCUR-0.71x

PEG Ratio

VTGNN/A

XCURN/A

Forward P/E (NTM)

VTGNN/A

XCURN/A

Forward P/S (NTM)

VTGNN/A

XCURN/A

Revenue (TTM)

VTGN$3M

XCUR$0

Revenue Growth (YoY)

VTGN278.5%

XCURN/A

Forward Rev Growth

VTGN4633.2%

XCUR0.0%

Gross Margin (TTM)

VTGN0.0%

XCUR0.0%

Operating Margin (TTM)

VTGN0.0%

XCUR0.0%

EBITDA Margin (TTM)

VTGN-2775.9%

XCUR0.0%

Net Margin (TTM)

VTGN-2702.6%

XCUR0.0%

FCF Margin (TTM)

VTGN-2493.3%

XCURN/A

Net Income (TTM)

VTGN$-68M

XCUR$-8M

FCF (TTM)

VTGN$-62M

XCUR$-7M

EPS (TTM)

VTGN-$1.57

XCUR-$1.30

ROE (TTM)

VTGN-15259.0%

XCUR-23791.0%

ROA (TTM)

VTGN-11745.0%

XCUR-6198.0%

ROIC (TTM)

VTGN-15162.0%

XCUR-23791.0%

Cash

VTGN$17M

XCUR$2M

Debt

VTGN$0

XCUR$0

Net Cash/Debt

VTGN$17M

XCUR$2M

Current Ratio (TTM)

VTGN3.07x

XCUR0.56x

Quick Ratio (TTM)

VTGN2.84x

XCUR0.43x

Debt/Equity (TTM)

VTGN0.00x

XCUR0.00x

Debt/Assets (TTM)

VTGN0.0%

XCUR0.0%

Interest Coverage (TTM)

VTGNN/A

XCURN/A

Net Debt/EBITDA (TTM)

VTGN0.00x

XCUR0.00x

Beta

VTGN0.49

XCUR3.86

52W Performance

VTGN-94.1%

XCUR-80.3%

YTD Performance

VTGN-65.2%

XCUR-81.2%

% from 52W High

VTGN-95.4%

XCUR-88.9%

% from 52W Low

VTGN19.2%

XCUR12.2%

Asset Turnover (TTM)

VTGN0.04x

XCUR0.05x

FCF Yield (TTM)

VTGN-644.0%

XCUR-105.0%

Earnings Yield (TTM)

VTGN-698.0%

XCUR-123.9%

Dividend Yield (TTM)

VTGNN/A

XCURN/A

Rule of 40

VTGN-2,214.8

XCUR0.0

EV/GP/RG

VTGNN/A

XCURN/A

Ticker research

View VTGN research View XCUR research

Metric	VTGN Vistagen Therapeutics Inc	XCUR Exicure Inc
Market & Valuation
Market Cap	$10M	$7M
Enterprise Value	$-7M	$5M
Price	$0.24	$1.05
P/E Ratio	N/A	N/A
P/S Ratio	3.87x	14.24x
EV/Sales	-2.92x	10.81x
EV/EBITDA	0.00x	0.90x
P/B Ratio	0.56x	7.29x
P/FCF Ratio	N/A	N/A
EV/FCF	0.12x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3M	$0
Revenue Growth (YoY)	278.5%	N/A
Forward Rev Growth	4633.2%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2775.9%	0.0%
Net Margin (TTM)	-2702.6%	0.0%
FCF Margin (TTM)	-2493.3%	N/A
Net Income (TTM)	$-68M	$-8M
FCF (TTM)	$-62M	$-7M
EPS (TTM)	-$1.57	-$1.30
ROE (TTM)	-15259.0%	-23791.0%
ROA (TTM)	-11745.0%	-6198.0%
ROIC (TTM)	-15162.0%	-23791.0%
Financial Health
Cash	$17M	$2M
Debt	$0	$0
Net Cash/Debt	$17M	$2M
Current Ratio (TTM)	3.07x	0.56x
Quick Ratio (TTM)	2.84x	0.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	3.86
52W Performance	-94.1%	-80.3%
YTD Performance	-65.2%	-81.2%
% from 52W High	-95.4%	-88.9%
% from 52W Low	19.2%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.05x
FCF Yield (TTM)	-644.0%	-105.0%
Earnings Yield (TTM)	-698.0%	-123.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,214.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View VTGN research	View XCUR research